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Abstract: High performance thin layer chromatography(HPTLC) is a fast separation technique which is  
advantageous in many means as it is simple to handle and requires a short analysis time to analyze the complex 
or the crude samples. A new, simple, precise and sensitive analytical method based on HPTLC technique has 
been developed and validated for the estimation of eighteen active ingredients and preservatives in various 
marketed pharmaceutical formulations. The proposed method was accurate and precise (mean recovery in the 
range from 83.3% to 98.8%, precision with RSD<3.95%; LOQ < 26.4 μg/mL). This method was applied for the 
quantification of active ingredients and preservatives in: ophthalmic solutions, nasal solution, otic solution, 
syrups, shampoos, suppositories, ointments, dietary supplements, tablets and capsules. 
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I.   INTRODUCTION 
From the stages of drug development to marketing and post marketing, analytical techniques play a 
great role, especially for understanding the physical and chemical stability of the drug, that have impact on the 
selection and design of the dosage form, assessing the stability of the drug molecules, quantification and 
identification of the impurities and degradation products, which are above the established threshold essential to 
evaluate the toxicity profiles, as well as, the content of drug in the marketed products [1]. Various analytical 
techniques as: UV-vis spectrophotometry [2-6], high performance thin layer chromatography (HPTLC) [7-10], 
high performance liquid chromatography (HPLC) [11-21], micellar electro- kinetic chromatography [22], 
sequential injection chromatography [23], and their corresponding analytical methods have been used in the 
analysis of pharmaceuticals. Although an old technique thin layer chromatography finds a lot of applications in 
the field of pharmaceutical analysis. With the advancement of the technique, HPTLC emerged as an important 
instrument in drug analysis. HPTLC is a fast separation technique and flexible enough to analyze a wide variety 
of samples. This technique is advantageous in many means as it is simple to handle and requires a short analysis 
time to analyze the complex or the crude samples. HPTLC evaluates the entire chromatogram with a variety of 
parameters without time limits. Moreover, there is simultaneous but independent development of multiple 
samples and standards on each plate, leading to an increased reliability of results. HPTLC has been used to 
quantitate drugs as ethinyl estradiol and cyproterone in tablets [7], alfuzosin in tablets [8], pentazocine and 
tramadol in mixtures [9], timolol maleate and brimonidine tartrate in ophthalmic solution [10], etc. The aim of 
our study was to develop and validate analytical methods based on a HPTLC technique for rapid, precise and 
reliable determination of active ingredients and preservatives in several different marketed pharmaceutical 
formulations. 
 
II. MATERIALS AND METHODS 
2.1 Instrumentation 
Application of the samples and standards on the TLC plates was performed by semiautomatic spotting 
device, Linomat IV, (Camag, Switzerland) with 100 μl syringe, (Hamilton, USA). Development of TLC plates 
was done in a horizontal chamber, 10 x10 cm (Camag, Switzerland). The spots were measured by TLC Scanner-
3, (Camag, Switzerland). The densitometric evaluation of HPTLC chromatograms was performed by CATS-4 
Software. 
All weighing were done on electronic analytical balance (Sartorius, Quintix65-1S). Calibrated 
volumetric flasks class A were used for the preparation of the standards and samples. Ultrasonic homogenizer 
(Hielscher, Germany) was used for the preparation of suppository samples. 
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2.2. Spotting parameters 
Band width: 5mm 
Space between 2 bands: 5mm 
Spraying rate: 10 μL/sec 
 
2.3. Scanning parameters 
Slit dimension: 4x.45 mm 
Lamp: Deuterium, Tungsten 
Measurement mode: Absorption 
 
III. SAMPLES 
Samples of marketed pharmaceutical formulations: ear drops oil solution (50 mg procaine 
hydrochloride and 50 mg phenazone per g), ophthalmic  water solution (1 mg naphazoline hydrochloride and 1 
mg diphenhydramine hydrochloride solution per mL), nasal drops water solution (0.1 mg dexamethasone 
sodium phosphate and 1 mg xylomethazoline hydrochloride per mL), ophthalmic water solution (sodium 
sulfacetamide 10%, W/V), ophthalmic water solution (0.5% timolol maleate, W/V), dietary supplement oil 
solution (retinyl palmitate 30,000 IU/mL; cholecalciferol 60,000 IU/mL), anti-parasitic shampoo water emulsion 
(1.2 mg pyrethrine I per mL and 1.8 mg pyrethrine II per mL), ointment (β- carotene 25%, W/W ), suppository 
(paracetamol 120 mg each), oral water solution mixture (metoclopramide 0.1%, W/V and Nipasol P 0.1%, 
W/V), oral water suspension mixture (paracetamol 24 mg per mL; Nipasol P 0.04%, W/V and Nipasol M 
0.08%, W/V), non-scored tablets (indapamide 2.5 mg per tablet) and capsules (nifedipine 5 mg per capsule) 
were obtained from the local pharmacy shops. 
 
IV. STANDARDS AND REAGENTS 
Analytical standards: procaine hydrochloride (purity ≥97%), phenazone (purity ≥98.5%), naphazoline 
hydrochloride (purity ≥99%), diphenhydramine hydrochloride (purity ≥98%), dexamethasone sodium phosphate 
(purity ≥98%), xylomethazoline hydrochloride (purity ≥98%), sulfacetamide sodium (purity ≥98%), timolol 
maleate (purity ≥98%), β-carotene (purity ≥97%), metoclopramide (purity ≥99.5%), indapamide (purity 
≥99.5%), nifedipine (purity ≥99.5%), nipasol M (purity ≥99.5%), nipasol P (purity ≥99.5%), oil mixture of 25% 
(W/V) pyrethrine I and 25% pyrethrine II (W/V) were obtained from Sigma-Aldrich (Netherlands). 
Analytical standard mixture consisted of retinyl palmitate (300,000 U/mL) and cholecalciferol (600,000 U/mL) 
was obtained from Alkaloid (Skopje, Macedonia). 
Ethyl acetate, methanol, n-butanol, anhydrous acetic acid, benzene, acetone, n-hexane, acetic acid and 
ammonia (25%, V/V) with analytical grade of purity were obtained from Alkaloid (Skopje, Macedonia). 
Distilled water was obtained from glass apparatus. 
 
4.1. Mobile phase systems 
1. Ethyl acetate: methanol: distilled water: ammonia 25%, V/V (8.5:2.0:1.5:0.5) 
2. N-butanol: anhydrous acetic acid: distilled water (6.0:2.0:2.0) 
3. Benzene: ethyl acetate (8.5:1.5) 
4. N-hexane: acetic acid (8.8:1.2) 
5. Benzene: acetone (8.0:2.0) 
 
4.2. Stationary phases 
1. Precoated HPTLC Kiesel silica gel 60 F254 glass plates 10x10 cm, layer thickness 0.25mm were obtained 
from Merck, Darmstadt (Germany). 
2. Precoated HPTLC RP8 F254 glass plates 10x10 cm, layer thickness 0.25mm were obtained from Merck, 
Darmstadt (Germany). 
 
V. PREPARATION OF THE SAMPLES AND STANDARD SOLUTIONS 
 
5.1. Oil solution (50 mg procaine hydrochloride per g and 50 mg phenazone per g) 
a. Preparation of the sample 
1g of the sample are transferred into a 100 mL volumetric flask and diluted with methanol up to the mark. 10 μL 
of the solution are applied onto the plate. 
b. Preparation of the standard solutions 
Stock solution: Procaine hydrochloride in methanol (1 mg/mL), phenazone in methanol (1 mg/mL). Working 
standard solution mixture: 5 mL of stock standard solution of procaine hydrochloride and phenazone are 
transferred into a 10 mL volumetric flask and diluted with methanol up to the mark (0.5 mg/L). 10 μL of the 
solution are applied onto the plate. 
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5.2. Water solution (1 mg naphazoline hydrochloride per mL and 1 mg diphenhydramine hydrochloride 
solution per mL) 
а.  Preparation of the sample 
2 mL of the sample are transferred into a 10 mL volumetric flask and filled up with methanol up to the mark. 20 
μL of the solution are applied onto the plate. 
b.  Preparation of the standard solutions 
Stock solutions of naphazoline hydrochloride (1 mg/mL) and diphenhydramine hydrochloride (1 mg/mL) are 
prepared in methanol. Working standard solution mixture is prepared by transferring 2 mL of stock standard 
solutions of naphazoline hydrochloride and diphenhydramine hydrochloride into a 10 mL volumetric flask and 
dilution with distilled water up to the mark (0.2 mg/mL). 20 μL of the solution are applied onto the plate. 
 
5.3. Water solution (0.1 mg dexamethasone sodium phosphate per mL and 1 mg xylomethazoline 
hydrochloride per mL) 
a. Preparation of the sample 
10 μL of the sample are directly applied onto the plate. 
b. Preparation of the standard solutions 
Stock standard solutions of dexamethasone sodium phosphate (1 mg/mL) and xylometazoline hydrochloride (1 
mg/mL) are prepared in distilled water. Working standard solution mixture is prepared by transferring of 1 mL 
stock standard solution of dexamethasone sodium phosphate and 5 mL of stock standard solution of 
xylometazoline hydrochloride to a 10 mL volumetric flask and dilution with distilled water up to the mark (0.1 
mg/L dexamethasone sodium phosphate, 0.5 mg/L xylometazoline hydrochloride).10 μL of the working 
standard solution are applied onto the plate. 
 
5. 4.  Sulfacetamide sodium water solution (10%) 
a. Preparation of the sample 
1 mL of the sample are transferred into a 50 mL volumetric flask and filled up with distilled water to the mark 
(i). 1 mL of the solution (i) is transferred into a 10 mL volumetric flask and diluted with distilled water up to the 
mark (ii). 5 μL of the solution (ii) is applied onto the plate. 
b. Preparation of the standard solutions 
Stock solution of sulfacetamide sodium (1 mg/mL) is prepared by dissolving 10 mg sulfacetamide in 10 mL 
distilled water (i). Working standard solution (0.2 mg/mL) is prepared by transferring 2 mL of stock standard 
solution (i) in a 10 mL volumetric flask and dilution with distilled water up to the mark (ii). 5 μL of the solution 
(ii) is applied onto the plate. 
 
5. 5. Timolol maleate water solution (0.5%) 
a. Preparation of the sample 
2 mL solution of eye drops is transferred into a 10 mL volumetric flask and filled up with methanol to the mark. 
10 μL of the solution is applied onto the plate. 
 
b. Preparation of the standard solution 
Stock solution of timolol maleate (1 mg/mL) was prepared by dissolving 10 mg timolol maleate in a 10 mL 
mixture methanol: distilled water (8:2). 10 μL of the stock solution is applied onto the plate. 
 
5. 6. Retinyl palmitate and cholecalciferol oil solution (30,000 IU/mL retinyl palmitate and 60,000 IU/mL 
cholecalciferol) 
a. Preparation of the sample 
1 mL of the sample are transferred in a 50 mL and diluted with n-hexane up to the mark. 5 μL of the solution is 
applied onto the plate. 
b. Preparation of the standard solutions 
Working standard mixture (i): 1 mL of stock standard solution of retinyl palmitate (300,000 IU/mL) and 1 mL 
of stock standard solution of cholecalciferol (600,000 IU/mL) are transferred into a 50 mL volumetric flask and 
filled up with n-hexane up to the mark. Working standard mixture (ii): 1 mL of working standard mixture (i) is 
transferred into a 10 mL volumetric flask and filled with n-hexane up to the mark. 5 μL of the solution is applied 
onto the plate. 
 
5. 7. Pyrethrine I and pyrethrine II water emulsion mixture (1.2 mg pyrethrine I per mL and 1.8 mg 
pyrethrine II per mL) 
a. Preparation of the sample 
1 mL of the solution is diluted with methanol up to 10 mL (b). 10 μL of the solution are applied onto the plate. 
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b. Preparation of the standard solutions 
0.5 mL of standard mixture (25% pyrethrine I and 25% pyrethrine II) is diluted up to 100 mL with n-hexane 
(i).1 mL of solution (i) is diluted up to 10 mL wit n-hexane (ii). 10 μL of the solution (ii) are applied onto the 
plate. 
 
5. 8.  β-carotene ointment (25%) 
a. Preparation of the sample 
25 mg of the sample are dissolved in 10 mL chloroform and filled up to 25 mL with chloroform. 5 μL of the 
solution are applied onto the TLC plate. 
b. Preparation of the standard solution 
10 mg of the standard are dissolved in 50 mL chloroform to obtain concentration of 0.20 g/L. 6 μL of the 
solution are applied onto the TLC plate. 
 
5. 9.  Paracetamol suppository (120 mg) 
a. Preparation of the sample 
1 suppository is dissolved in 50 mL methanol and placed on the water bath at 50 
0
C until complete dissolution. 
After the cooling the solution is filtered through the milipore membrane filter 0.45 μm into a 200 mL volumetric 
flask and filled up to the mark with methanol (i). 5 mL of the solution are transferred into a 50 mL volumetric 
flask and filled up with methanol to the mark (ii).10 μL of the solution (ii) are applied onto the plate. 
b. Preparation of the standard solutions 
Stock standard solution of paracetamol (0.6 mg/mL) was prepared in methanol (i). 1 mL of stock standard 
solution (i) was transferred into a 10 mL volumetric flask and filled up with methanol to the mark (ii).10 μL of 
the working standard solution (ii) were applied onto the plate. 
 
5. 10. Metoclopramide water solution (0.1% metoclopramide per mL and 0.1% Nipasol P per mL) 
a. Preparation of the sample 
1 mL of the sample is transferred into a 10 mL flask and diluted with methanol up to the mark. 10 μL of the 
solution are applied onto the plate. 
b. Preparation of the standard solutions 
Stock solution: 10 mg metoclopramide is diluted with methanol in 10 mL volumetric flask to obtain 
concentration of 1 mg/mL (i). 10 mg nipasol P is diluted with methanol in 10 mL volumetric flask to obtain 
concentration of 1 mg/mL (ii). 1 ml of the stock solution (i) and 1 mL of the stock solution (ii) are transferred in 
a 10 mL volumetric flask and filled up with methanol to the mark to obtain concentration of 0.1 g/L (iii). 10 μL 
of the working standard solution (iii) are applied onto the plate. 
 
5. 11. Paracetamol water suspension (24 mg paracetamol/mL, 0.04% nipasol P, 0.08% nipasol M) 
a. Preparation of the sample 
1a. Preparation of the sample and working standard solution for the determination of paracetamol 
1 mL of the sample is transferred into a 250 mL volumetric flask and diluted with methanol up to the mark. 10 
μL of the solution is applied onto the plate. 
Preparation of the standard solutions 
10 mg paracetamol are dissolved with methanol in a 10 mL volumetric flask and diluted with methanol to obtain 
concentration of 1 mg/mL (i). 1 mL of stock solution (i) is transferred into a 10 mL volumetric to obtain 
concentration of 0.1 g/L (ii). 10 μL of the working standard (ii) is applied onto the plate. 
1b. Preparation of the sample for determination of  Nipasol P and Nipasol M 
1 mL of the sample is transferred into a 10 mL volumetric flask. 5 μL of the solution are applied onto the plate. 
Preparation of  the working standard solution 
4 mL of stock standard solutions of Nipasol P (1 mg/mL) and 8 mL of Nipasol M (1 mg/mL) prepared in 
methanol are transferred into a 100 mL volumetric flask and diluted  with methanol up to the mark (40 mg/L 
Nipasol P, 80 mg/L Nipasol M). 5 μL of the working standard solution mixture are applied onto the plate. 
 
5. 12.  Indapamide tablets (2.5 mg) 
a. Preparation of the samples 
2 tablets are dissolved in 20 mL methanol. After sonication, the solution is filtered through the membrane 
milipore filter 0.45 μm in a 50 mL volumetric flask and filled up with methanol to the mark. 10 μL of the 
solution are applied onto the plate. 
b. Preparation of the standards 
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Stock solution of indapamide (1 mg/mL) is prepared in methanol. 1 mL of the stock solution is transferred to a 
10 mL volumetric flask and diluted with methanol up to the mark (0.1 mg/mL).10 μL of working standard 
solution are applied onto the plate. 
 
5. 13.  Nifedipine capsules (5 mg) 
a. Preparation of the sample 
2 capsules are extracted with 20 mL methanol. After sonication, the solution is filtered through the milipore 
membrane filter into a 50 mL volumetric flask. 10 μL of the solution is applied onto the plate. 
b. Preparation of the standard solutions 
Nifedipine stock solution (1 mg/mL) is prepared in methanol. 2 mL of stock solution are transferred into a 10 
mL volumetric flask and filled with methanol up to the mark (0.2 mg/mL). 10 μL of the working solution are 
applied onto the plate. 
 
VI. RESULTS AND DISCUSSION 
6.1. Method optimization 
In order to obtain the best separation for all tested components, a series of preliminary investigations using 
different mobile and stationary phases were tested. The optimum separation of components of interest was 
achieved with mobile phases and stationary phases shown in Table 1. 
 
Table 1. Experimental (chromatographic) conditions for the determination of the active and preservatives in 
various pharmaceutical formulations 
Pharmaceutical 
dosage form 
Active component Stationary 
phase 
Mobile phase *HRf  (%) Wavelength 
(nm) 
Ear drops 
(oil solution) 
Procaine 
hydrochloride 
1 1 67 254 
 Phenazone 1 1 37 254 
Eye drops 
(water solution) 
Naphazoline 
hydrochloride 
1 1 5 254 
 Diphenhydramine 
hydrochloride 
1 1 35 254 
Nasal drops 
(water solution) 
Dexamethasone 
sodium phosphate 
1  
 
Development 
with mobile 
phase 1, after 
drying 
development 
with mobile 
phase 2 
54 254 
 Xylomethazoline 
hydrochloride 
1  82 254 
Eye drops 
(water solution) 
Sulfacetamide 
sodium 
1 1 86 254 
Eye drops 
(water solution) 
Timolol maleate 1 1 30 254 
Dietary supplement Retinyl palmitate 2 1 53 254 
(oil solution) Cholecalciferol 2 1 73 254 
Ointment β carotene 2 1 70 430 
Tablets Indapamide 1 5 47 254 
Capsules Nifedipine 1 1 93 254 
Shampoo Pyrethrine II 1 3 76 254 
(water emulsion) Pyrethrine I 1 3 87 254 
Syrup Metoclopramide 1 1 26 254 
(water solution) Nipasol P 2 4 62 270 
Syrup Paracetamol 1 1 81 254 
(water suspension) Nipasol M 
Nipasol P 
2 
2 
4 
4 
43 
63 
270 
270 
*Hrf – retention factor (Rf) •100 
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Chromatograms of some of the analyzed components are shown in Fig. 1. 
 
Figure. 1 Chromatograms of some of the tested components 
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6.2. Method validation 
6.2.1. Recovery, precision and linearity 
Recovery, precision and linearity of all the tested components were determined using fortified samples of 
pharmaceutical formulations which were previously tested on the presence of active ingredients and 
preservatives. In each case, 5 replicates each at 5 levels were fortified into the samples. The obtained results for 
recovery (R) and precision (RSD) are shown in Table 2. 
 
Table 2.   Recovery data obtained with the proposed methods 
Component Concentration 
present 
(μg/mL) 
Concentration 
added (μg/mL) 
Concentration 
found 
(μg/mL) 
Recovery 
(%) 
RSD 
(%), 
n=3 
Procaine hydrochloride 500 200 680 97.1 2.32 
Phenazone 500 200 692 98.8 2.45 
Naphazoline 
hydrochloride 
200 100 285 95.5 1.98 
Diphenhydramine 
hydrochloride 
200 100 276 92.0 2.87 
Dexamethasone sodium 
phosphate 
100 50 139 92.7 2.05 
Xylomethazoline 
hydrochloride 
500 200 673 96.1 1.97 
Sulfacetamide sodium 200 150 332 94.9 3.05 
Timolol maleate 500 200 635 90.7 3.12 
*Retinyl palmitate 330 200 490 92.4 3.23 
**Cholecalciferol 30 20 42 84.0 3.95 
Pyrethrine I 700 300 930 93.0 2.15 
Pyrethrine II 700 300 894 89.4 2.55 
β-carotene 200 150 305 87.1 2.90 
Paracetamol (suppository) 60 30 82   
Paracetamol (syrup) 96 50 135 92.5 1.85 
***Nipasol P 40 20 50 83.3 3.15 
Nipasol M 80 40 108 90.0 2.51 
Metoclopramide 100 50 139 92.3 2.90 
****Nipasol P 100 50 141 94.0 1.85 
Indapamide 100 50 144 96.0 1.55 
Nifedipine 200 100 283 94.3 2.35 
*Retinyl palmitate 1IU=0.55 μg 
**Cholecalciferol 1IU=0.025 μg 
***Nipasol P in Paracetamol syrup formulation 
** **Nipasol P in Metoclopramide water solution formulation 
 
High analytical recoveries ranging from 83.3% to 98.8% were obtained for all the tested components. From the 
obtained values for relative standard deviation (RSD), ranging from 1.55% to 3.95% indicated that the proposed 
method is precise enough and therefore suitable for the determination of tested compounds in pharmaceutical 
formulations. 
The obtained values for multiple correlation coefficients (Table 3), ranged from 0.990 to 0.998, revealed that the 
method has a good linearity for all the tested components, and are in line with methods performed by methods 
based on HPLC technique [11-21]. 
The limit of detection (LOD) and the limit of quantification (LOQ) were calculated according to the formulas 
LOD = 3.3 · SD/slope and LOQ = 10 · SD/slope [24]. The obtained results are shown in Table 3. 
 
 
 
 
 
 
 
Application of high performance thin layer chromatography 
14 
Table 3.  Statistical data for limit of detection (LOD), limit of quantification (LOQ) and correlation coefficient 
(R2) 
 
Component Range 
(μg/mL) 
R2 
 
LOD (μg/mL) LOQ 
(μg/mL) 
Procaine hydrochloride 50-500 0.992 6 19.8 
Phenazone 50-500 0.995 7 23.1 
Naphazoline hydrochloride 20-200 0.991 5 16.5 
Diphenhydramine hydrochloride 20-200 0.996 5 16.5 
Dexamethasone sodium phosphate 10-100 0.995 2 6.6 
Xylomethazoline hydrochloride 50-500 0.998 5 16.5 
Sulfacetamide sodium 20-200 0.995 6 19.8 
Timolol maleate 50-500 0.992 8 26.4 
Retinyl palmitate 30-300 0.990 7 23.1 
Cholecalciferol 5-30 0.991 1 3.3 
Pyrethrine I 100-700 0.994 8 26.4 
Pyrethrine II 100-700 0.990 7 23.1 
β-carotene 20-200 0.991 5 16.5 
Paracetamol 10-100 0.997 2 6.6 
Nipasol P 4 - 40 0.995 1 3.3 
Nipasol M 8 - 80 0.993 2 6.6 
Metoclopramide 10-100 0.997 2 6.6 
Indapamide 10-100 0.998 3 9.9 
Nifedipine 20-200 0.995 3 9.9 
 
VII. CONCLUSIONS 
Analytical methods based on a HPTLC technique were developed for rapid, precise and reliable 
determination of active ingredients and preservatives in 13 different pharmaceutical formulations taken from the 
market. From the validation parameters obtained it can be concluded that this methods are useful for routine 
analyses in determining the quality of the marketed pharmaceutical formulations. The proposed method is 
precise enough with corresponding methods based on the HPLC technique. 
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